ExoSphere

We aim to enable earlier intervention by developing diagnostic technology
designed to detect cancer at its earliest, most treatable stages.

ExoSphere is pioneering a new approach that combines advanced microfluidics
with highly sensitive biomarker detection technology.

Unique Techology

Our platform is being developed to capture and detect disease-specific molecules at extremely low concentrations, with the goal of enabling earlier and more sensitive detection than current standard methods.

Speed, Affordability, Scalability

Unlike conventional technologies, our solution emphasizes speed, affordability, and scalability without compromising precision. Our goal is for the platform to be suitable not only for cutting-edge research but also, pending clinical validation and regulatory clearance, for broad clinical use.

Applications

Our platform has broad applications across oncology diagnostics and beyond, including areas such as cardiovascular and infectious diseases. While the technology is versatile, we have active clinical pilots underway on our first target indications.